A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo

Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
11/2001
11/22/2001	WO2001087353A1 Preparations for diagnosing infection with helicobacter pylori
11/22/2001	WO2001087352A1 Reverse isotope dilution assay and lactose intolerance assay
11/22/2001	WO2001087348A2 Multifunctional nanodevice platform
11/22/2001	WO2001008660A3 Targeted fiberless radiative effectors
11/22/2001	WO2000055633A9 Methods of screening for colorectal cancer modulators
11/22/2001	US20010044567 Bioabsorbable brachytherapy device
11/22/2001	US20010044543 Imaging agents for diagnosis of Parkinson's disease
11/21/2001	EP1154803A1 Immobilized labeling compounds and methods
11/21/2001	EP1154798A1 Molecules for the treatment and diagnosis of tumors
11/21/2001	EP0876161B1 Contrast media
11/21/2001	CN1322727A Tc-99m labelled Tc-N nucleated isonitrile compound and its preparation and application
11/21/2001	CN1322575A Myocardial developer and its prepn
11/20/2001	US6319953 Provides preclinical screens for anxiolytic and antidepressant activity of nk-1 receptor antagonists.
11/20/2001	US6319500 Detection and treatment of infections with immunoconjugates
11/20/2001	US6319498 Amyloidogenic protein, or fragment thereof, modified with cis-decalin group, cholanoyl structure, cholyl group, diethylenetriaminepentaacetyl group, menthoxyacetyl group, fluorescein-containing group, or n-acetylneuraminyl group
11/20/2001	CA2156390C Technetium-99m labeled peptides for diagnostic imaging
11/15/2001	WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001	WO2001085221A2 Assessing levels of o6-alkylguanine-dna alkyltransferase in vivo
11/15/2001	WO2001085220A1 Labeled nucleosides and method for their preparation
11/15/2001	WO2001085219A2 Identification, diagnosis, and treatment of breast cancer
11/15/2001	WO2001085218A2 Acylated cyclodextrin guest inclusion complexes
11/15/2001	WO2001017569A3 Improved container composition for radiopharmaceutical agents
11/15/2001	WO2001017567A3 Improved container composition for diagnostic agents
11/15/2001	WO2000053232A9 Matriptase, a serine protease and its applications
11/15/2001	US20010041713 Cyclooxygenase-2 (COX-2); administering 2-(2-methylpyrid-5-yl),3-(p-methylsulfonylphenyl),5-chloro-pyridine, or salt, hydrate or N-oxide thereof, alone or in combination with other drugs
11/15/2001	US20010041689 Bisphosphonate conjugates and methods of making and using the same
11/15/2001	CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/14/2001	CN1321696A Polyether-polyamino acid double block copolymer and its preparation method and application
11/14/2001	CN1074766C Alkylaminobenzothiazole and -benzoxazole derivatives
11/13/2001	US6316024 Therapeutic liposome composition and method of preparation
11/13/2001	US6315979 Administering to an animal in vivo in an implantable catheter radioiodinated phenol derivative for brachytherapy
11/08/2001	WO2001083781A2 14094, a novel human trypsin family member and uses thereof
11/08/2001	WO2001083693A2 Compounds having affinity for the vascular endothelial growth factor receptor-2 (vegfr-2) and associated uses
11/08/2001	WO2001083520A2 Polyacid glycopeptide derivatives
11/08/2001	WO2001083436A2 Small technetium-99m and rhenium labeled agents and methods for imaging tumors
11/08/2001	WO2001083425A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
11/08/2001	WO2001082978A2 Imaging of nicotinic acetylcholine receptor subtypes
11/08/2001	WO2001082975A2 Membrane-permeant peptide complexes for medical imaging
11/08/2001	WO2001082974A2 Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability
11/08/2001	WO2001082971A2 Cyclodextrin containing glycopeptide antibiotic compositions
11/08/2001	WO2001082871A2 Method of using zinc isotope for therapy and diagnosis of colon cancer
11/08/2001	WO2001082864A2 18f-labeled choline analogs
11/08/2001	WO2001036485A3 Recombinant monoclonal antibodies recognizing antigen ior c2 and the use thereof in the diagnosis and treatment of colorectal tumors
11/08/2001	WO2000076556A9 High dose radionuclide complexes for bone marrow suppression
11/08/2001	US20010039017 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
11/08/2001	US20010039016 Measurement, calibration gene expression
11/08/2001	US20010038851 Therapeutic liposome composition and method of preparation
11/08/2001	US20010038822 Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma
11/08/2001	CA2726789A1 Cyclodextrin containing glycopeptide antibiotic compositions
11/08/2001	CA2407399A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/08/2001	CA2405611A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
11/07/2001	EP1151997A1 Polychelants, their complexes with metal ions, their preparation and their uses
11/07/2001	EP1150658A2 Method for controlling liposome size
11/07/2001	EP0651768B1 USE OF p97 IN THE DIAGNOSIS OF ALZHEIMER DISEASE
11/06/2001	US6313274 Subjecting to ultraviolet radiation to reduce some disulfide bonds and generate thiol moieties; reacting with antibody, ultraviolet radiation to reduce some disulfide bonds and reacting with chemical; labeling antibodies
11/06/2001	US6312694 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
11/06/2001	US6312661 Method for the detection and localization of ductal exocrine pancreas tumours
11/01/2001	WO2001081544A2 Identification and uses of a hyaluronan receptor
11/01/2001	WO2001081426A2 Rgd (arg-gly-asp) coupled to (neuro)peptides
11/01/2001	WO2001080906A2 Radiometal complexes of 2-pyrrolylthiones for imaging a therapy
11/01/2001	WO2001080884A1 Intrathecal administration of rituximab for treatment of central nervous system lymphomas
11/01/2001	WO2001080880A2 Apoptotic agents
11/01/2001	US20010036635 Cancer screening
11/01/2001	CA2410024A1 Identification and uses of a hyaluronan receptor
11/01/2001	CA2406852A1 Radiometal complexes of 2-pyrrolylthiones and their use as radiopharmaceuticals for imaging and therapy
11/01/2001	CA2405632A1 Intrathecal administration of rituximab for treatment of central nervous system lymphomas
10/2001
10/31/2001	EP1149592A2 Radioactively coated devices
10/31/2001	EP1149111A1 Method and composition for angiogenesis inhibition
10/31/2001	EP1149095A1 Novel azabicyclo derivatives and their use
10/31/2001	EP1149057A1 Biodegradable glass compositions and methods for radiation therapy
10/31/2001	EP1148878A1 1,4,8,11-tetraazacyclotetradecane derivatives as radiodiganostic agents and their use in determining hypoxia and radioresistance of tumors
10/31/2001	CN1320044A Combination therapies for B-cell lymphomas comprising administration of anti-CD 20 antibody
10/31/2001	CN1073860C Method for preparing radiopharmaceutical kit for bone tumour curing or diagnosis
10/30/2001	US6309636 Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides
10/30/2001	US6309634 Methods of treating Parkinson's disease using recombinant adeno-associated vector (rAAV)
10/30/2001	CA2090700C Modified antibodies with controlled clearance time
10/25/2001	WO2001079171A1 Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system
10/25/2001	WO2001027159A3 Polypeptides for detection and elimination of ca19-9 antigen positive cells
10/25/2001	US20010034363 Water soluble paclitaxel derivatives
10/24/2001	EP1147116A1 Boron steroid mimics and pharmaceutical compositions
10/24/2001	EP1147111A1 Cryptate compounds and methods for diagnosis and therapy
10/24/2001	EP1146913A2 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation
10/24/2001	EP1146912A1 Method for improved radiation therapy
10/24/2001	EP0809698B1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6
10/23/2001	US6306882 Fluoroalkylpiperidine esters cognition activators and alzheimer's
10/23/2001	US6306393 Administering to subject having a b-cell related malignancy a therapeutic composition comprising a pharmaceutically acceptable carrier and a combination of at least one naked anti-cd19 antibody and an anfi-cd20 antibody
10/23/2001	US6306073 Apparatus and method for treating a disease process in a luminal structure with a radionuclide and chelating agent
10/23/2001	CA2137561C Photoactivation of proteins for conjugation purposes
10/18/2001	WO2001077179A1 Proteins with a high immunoreactivity and a method for the production thereof
10/18/2001	WO2001077145A2 Integrin binding peptide derivatives
10/18/2001	WO2001077122A1 Ternary ligand complexes useful as radiopharmaceuticals
10/18/2001	WO2001077102A1 Macrocyclic chelants for metallopharmaceuticals
10/18/2001	WO2001076645A2 Targeted agents useful for diagnostic and therapeutic applications
10/18/2001	WO2001076644A2 Lipid-based systems for targeting diagnostic agents
10/18/2001	WO2001076556A2 Lipid-based drug delivery systems against parasitic infections
10/18/2001	WO2001076555A2 Lipid-based drug delivery systems for topical application
10/18/2001	WO2001031015A3 36p6d5: secreted tumor antigen
10/18/2001	US20010031035 Functional radiographic imaging methods and agents
10/18/2001	DE10016877A1 (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung (Glyco) proteins with high immunoreactivity, and a method for their preparation
10/18/2001	CA2404290A1 Ternary ligand complexes useful as radiopharmaceuticals

1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 243